Category:
Prophylactic Biological Products
CAS NO:
NA
Standard:
In-house Standards,
Olmesartan Medoxomil + Amlodipine is a fixed-dose combination antihypertensive agent. The synthesis involves coupling olmesartan medoxomil (C29H30N6O6, CAS 144685-63-6) with amlodipine besylate (C51H56Cl2N10O10S2). This formulation utilizes solid-state blending or co-crystallization to enhance bioavailability and patient compliance for chronic hypertension management.
Contraindicated in pregnancy due to fetal toxicity; requires strict storage below 25°C in dry conditions. Regulatory compliance mandates rigorous quality control for impurity profiles during large-scale production.